Maternal circulating levels of some metabolic syndrome biomarkers in gestational diabetes mellitus

Endocrine

Volumn 51, Issue 2, 2016, Pages 245-255

  Khosrowbeygi, Ali ^a,b   Shiamizadeh, Najmeh ^a   Taghizadeh, Nima ^a  

^a LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adenosine deaminase; Amylase; Atherogenic index; Gamma glutamyltransferase; Gestational diabetes mellitus; Insulin resistance

Indexed keywords

ADENOSINE DEAMINASE; ADIPONECTIN; ALPHA AMYLASE SALIVA ISOENZYME; BIOLOGICAL MARKER; CHOLINESTERASE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ADIPOQ PROTEIN, HUMAN; BILIRUBIN; GLUCOSE BLOOD LEVEL; INSULIN; LIPID;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME ACTIVITY; FEMALE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; BODY MASS; GLUCOSE BLOOD LEVEL; PREGNANCY;

ADIPONECTIN; ADULT; BILIRUBIN; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES, GESTATIONAL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; METABOLIC SYNDROME X; PREGNANCY;

EID: 84956901930     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-015-0697-4     Document Type: Article

References (33)

1. M. Aslan, O. Celik, N. Celik, I. Turkcuoglu, E. Yilmaz, A. Karaer, Y. Simsek, E. Celik, S. Aydin, Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus. Endocrine 41, 424–429 (2012)
2. M.I. Yeral, A.S. Ozgu-Erdinc, D. Uygur, K.D. Seckin, M.F. Karsli, A.N. Danisman, Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial. Endocrine 46, 512–518 (2014)
3. J.G. Lee, S.W. Park, B.M. Cho, S. Lee, Y.J. Kim, D.W. Jeong, Y.H. Yi, Y.H. Cho, Serum amylase and risk of the metabolic syndrome in Korean adults. Clin. Chim. Acta 412, 1848–1853 (2011)
4. K. Nakajima, T. Nemoto, T. Muneyuki, M. Kakei, H. Fuchigami, H. Munakata, Low serum amylase in association with metabolic syndrome and diabetes: a community-based study. Cardiovasc. Diabetol. 10, 34 (2011). doi:10.1186/1475-2840-10-34
5. Y. Zhao, J. Zhang, J. Zhang, J. Wu, Y. Chen, Metabolic syndrome and diabetes are associated with low serum amylase in a Chinese asymptomatic population. Scand. J. Clin. Lab. Invest. 74, 235–239 (2014)
6. J. Yao, Y. Zhao, J. Zhang, Y. Hong, H. Lu, J. Wu, Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients. Lipids Health Dis. 13, 185 (2014). doi:10.1186/1476-511X-13-185
7. K. Ryckman, C. Spracklen, C. Smith, J. Robinson, A. Saftlas, Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG 122, 643–651 (2015)
8. P.C. Tan, S. Mubarak, S.Z. Omar, Gamma-glutamyltransferase level in pregnancy is an independent risk factor for gestational diabetes mellitus. J. Obstet. Gynaecol. Res. 34, 512–517 (2008)
9. I. Alanbay, H. Coksuer, M. Ercan, U. Keskin, E. Karasahin, M. Ozturk, S. Tapan, O. Ozturk, I. Kurt, A. Ergun, Can serum gamma-glutamyltransferase levels be useful at diagnosing gestational diabetes mellitus? Gynecol. Endocrinol. 28, 208–211 (2012)
10. P.C. Tan, A.Z. Aziz, I.S. Ismail, S.Z. Omar, Gamma-glutamyltransferase, alanine transaminase and aspartate transaminase levels and the diagnosis of gestational diabetes mellitus. Clin. Biochem. 45, 1192–1196 (2012)
11. H. Liu, M. Shao-Gang, C. Liang, B. Feng, X. Wei, Surrogate markers of the kidney and liver in the assessment of gestational diabetes mellitus and fetal outcome. J. Clin. Diagn. Res. 9, OC14-7 (2015). doi:10.7860/JCDR/2015/11585.5475
12. M.G. Gohel, A.N. Chacko, Serum GGT activity and hsCRP level in patients with type 2 diabetes mellitus with good and poor glycemic control: an evidence linking oxidative stress, inflammation and glycemic control. J. Diabetes Metab. Disord. 12, 56 (2013)
13. S.Y. Lee, E. Sung, Y. Chang, Elevated serum gamma-glutamyltransferase is a strong marker of insulin resistance in obese children. Int. J. Endocrinol. 2013, 578693 (2013). doi:10.1155/2013/578693
14. A. Sunto, K. Mochizuki, R. Miyauchi, Y. Misaki, M. Shimada, N. Kasezawa, K. Tohyama, T. Goda, Serum γ-GTP activity is closely associated with serum CRP levels in non-overweight and overweight middle-aged Japanese men. J. Nutr. Sci. Vitaminol (Tokyo) 59, 108–114 (2013)
15. K.S. De Bona, G. Bonfanti, P.E. Bitencourt, L.O. Cargnelutti, P.S. da Silva, L. De Lucca, V.C. Pimentel, E. Tatsch, T.L. Gonçalves, M. Premaor, R.N. Moresco, M.B. Moretto, Butyrylcholinesterase and γ-glutamyltransferase activities and oxidative stress markers are altered in metabolic syndrome, but are not affected by body mass index. Inflammation 36, 1539–1547 (2013)
16. N.G. Vallianou, A.A. Evangelopoulos, V. Bountziouka, M.S. Bonou, C. Katsagoni, E.D. Vogiatzakis, P.C. Avgerinos, J. Barbetseas, D.B. Panagiotakos, Association of butyrylcholinesterase with cardiometabolic risk factors among apparently healthy adults. J. Cardiovasc. Med. (Hagerstown) 15, 377–383 (2014)
17. L.P. Cocelli, E. Dikensoy, H. Cicek, Y. Ibar, S. Kul, O. Balat, Pseudocholinesterase in gestational diabetes: positive correlation with LDL and negative correlation with triglyceride. Arch. Gynecol. Obstet. 286, 43–49 (2012)
18. L.O. Guimarães, F.A. de Andrade, G.F. Bono, T.E. Setoguchi, M.B. Brandão, E.A. Chautard-Freire-Maia, I.C. Dos Santos, G. Picheth, A.C. Faria, R.R. Réa, R.L. Souza, L. Furtado-Alle, Gestational diabetes mellitus (GDM) decreases butyrylcholinesterase (BChE) activity and changes its relationship with lipids. Genet. Mol. Biol. 37, 1–6 (2014)
19. R. Wang, G. Yang, Z. Lyu, J. Dou, W. Gu, L. Zang, N. Jin, J. Du, J. Ouyang, Q. Guo, X. Wang, L. Yang, J. Ba, Y. Mu, A correlation study between serum direct bilirubin and lipid in type 2 diabetic patients. Zhonghua. Nei. Ke. Za. Zhi. 53, 783–787 (2014)
20. M. Mokhtari, M. Hashemi, M. Yaghmaei, F. Molashahi, A. Shikhzadeh, A. Niazi, S. Ghavami, Serum adenosine deaminase activity in gestational diabetes mellitus and normal pregnancy. Arch. Gynecol. Obstet. 281, 623–626 (2010)
21. C.J. Homko, New recommendations for the diagnosis of diabetes in pregnancy. Curr. Diabetes Rep. 11, 1–3 (2011)
22. W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–503 (1972)
23. L. Zhang, S. Chen, A. Deng, X. Liu, Y. Liang, X. Shao, M. Sun, H. Zou, Association between lipid ratios and insulin resistance in a Chinese population. PLoS One 10, e0116110 (2015). doi:10.1371/journal.pone.0116110
24. D. Wang, S. Xu, H. Chen, L. Zhong, Z. Wang, The associations between triglyceride to high-density lipoprotein cholesterol ratios and the risks of gestational diabetes mellitus and large-for-gestational-age infant. Clin. Endocrinol. (Oxf) (2015). doi:10.1111/cen.12742
25. X. Jia, S. Wang, N. Ma, X. Li, L. Guo, X. Liu, T. Dong, Y. Liu, Q. Lu, Comparative analysis of vaspin in pregnant women with and without gestational diabetes mellitus and healthy non-pregnant women. Endocrine 48, 533–540 (2015)
26. S.M. Li, W.F. Wang, L.H. Zhou, L. Ma, Y. An, W.J. Xu, T.H. Li, Y.H. Yu, D.S. Li, Y. Liu, Fibroblast growth factor 21 expressions in white blood cells and sera of patients with gestational diabetes mellitus during gestation and postpartum. Endocrine 48, 519–527 (2015)
27. E.M. Akbas, A. Timuroglu, A. Ozcicek, F. Ozcicek, L. Demirtas, A. Gungor, N. Akbas, Association of uric acid, atherogenic index of plasma and albuminuria in diabetes mellitus. Int. J. Clin. Exp. Med. 7, 5737–5743 (2014)
28. E. Oda, Cross-sectional and longitudinal associations between serum bilirubin and dyslipidemia in a health screening population. Atherosclerosis 239, 31–37 (2015)
29. Y.G. Sargisova, N.A. Andreasyan, H.L. Hayrapetyan, H.A. Harutyunyan, Nitric oxide—an activating factor of adenosine deaminase 2 in vitro. Biochemistry (Mosc) 77, 92–97 (2012)
30. V.K. Khemka, D. Bagchi, A. Ghosh, O. Sen, A. Bir, S. Chakrabarti, A. Banerjee, Raised serum adenosine deaminase level in nonobese type 2 diabetes mellitus. ScientificWorldJournal 2013, 404320 (2013). doi:10.1155/2013/404320
31. L. Tao, E. Gao, X. Jiao, Y. Yuan, S. Li, T.A. Christopher, B.L. Lopez, W. Koch, L. Chan, B.J. Goldstein, X.L. Ma, Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115, 1408–1416 (2007)
32. A. Khosrowbeygi, H. Ahmadvand, Positive correlation between serum levels of adiponectin and homocysteine in pre-eclampsia. J. Obstet. Gynaecol. Res. 39, 641–646 (2013)
33. R. Yao, Y. Zhou, Y. He, Y. Jiang, P. Liu, L. Ye, Z. Zheng, W.B. Lau, Y. Cao, Z. Zeng, Adiponectin protects against paraquat-induced lung injury by attenuating oxidative/nitrative stress. Exp. Ther. Med. 9, 131–136 (2015)